Making sense of health statistics
... relative risks and 5-year-survival rates, which mislead many people, absolute risks and mortality rates provide transparent tools for risk communication. Relative versus absolute risks. The British Committee on Safety of Medicines issued a warning in 1995 that the third-generation oral contraceptive ...
... relative risks and 5-year-survival rates, which mislead many people, absolute risks and mortality rates provide transparent tools for risk communication. Relative versus absolute risks. The British Committee on Safety of Medicines issued a warning in 1995 that the third-generation oral contraceptive ...
50 incidence of clinically indolent PCa versus a rate of 14.6 in
... FIG. 5. Nomogram for full model. Pre.Tx., pretreatment. Clin., clinical. Pri.Bx.Gl, primary biopsy Gleason score. Sec.Bx.Gl, secondary biopsy Gleason score. U/S, ultrasound. Prob., probable. ...
... FIG. 5. Nomogram for full model. Pre.Tx., pretreatment. Clin., clinical. Pri.Bx.Gl, primary biopsy Gleason score. Sec.Bx.Gl, secondary biopsy Gleason score. U/S, ultrasound. Prob., probable. ...
High-dose prostate therapy that halves trips to hospital
... So when he was offered the chance to take part in a trial that meant just 20 sessions of radiation - at higher doses - he didn't hesitate. David was diagnosed with prostate cancer five years ago. He'd been going to the loo up to six times a night, which can be a symptom of the disease, but had initi ...
... So when he was offered the chance to take part in a trial that meant just 20 sessions of radiation - at higher doses - he didn't hesitate. David was diagnosed with prostate cancer five years ago. He'd been going to the loo up to six times a night, which can be a symptom of the disease, but had initi ...
One Page Summary - Word 20 KB - Medical Services Advisory
... Tolerance of normal tissues is the limiting factor for the dose of radiation that can be delivered to the tumour. CRT aims to limit exposure of normal tissues to radiation and increase the dose to the tumour. In treating prostate cancer some randomised evidence suggests that delivery of similar dose ...
... Tolerance of normal tissues is the limiting factor for the dose of radiation that can be delivered to the tumour. CRT aims to limit exposure of normal tissues to radiation and increase the dose to the tumour. In treating prostate cancer some randomised evidence suggests that delivery of similar dose ...
prostatic acid phosphatase testing
... Recent work, suggesting it has a role in prognosticating intermediate and high-risk prostate cancer, has led to renewed interest in this marker.2 However the American Urological Association states that PSA is the best predictor of skeletal metastases found on radionuclide bone scan.3 New biochemical ...
... Recent work, suggesting it has a role in prognosticating intermediate and high-risk prostate cancer, has led to renewed interest in this marker.2 However the American Urological Association states that PSA is the best predictor of skeletal metastases found on radionuclide bone scan.3 New biochemical ...
To Test or Not To Test for Prostate Cancer
... Prostate cancer is different from many cancers because it often grows very slowly. In 2014, only about 29,500 Americans will die from prostate cancer, compared to 222,000 men diagnosed with the disease. Many men with prostate cancer will never know they have it unless they get tested. In these cases ...
... Prostate cancer is different from many cancers because it often grows very slowly. In 2014, only about 29,500 Americans will die from prostate cancer, compared to 222,000 men diagnosed with the disease. Many men with prostate cancer will never know they have it unless they get tested. In these cases ...
Prostate Cancer Panel Fact Sheet
... and its association with an increased risk of cancers and/or tumors is unknown. In other words, it cannot be determined yet whether this variant is associated with an increased risk of cancer and/or tumors or it is a harmless (normal) variant. A negative result means that no reportable variants were ...
... and its association with an increased risk of cancers and/or tumors is unknown. In other words, it cannot be determined yet whether this variant is associated with an increased risk of cancer and/or tumors or it is a harmless (normal) variant. A negative result means that no reportable variants were ...
Primary care providers and prostate cancer care
... • Modified to serve as a point-of-care resource and to facilitate care transitions and coordination between specialty and primary care. • Patient-reported symptom assessment • Distinctions between medical and self-management strategies for prostate cancer treatment-related side effects • Strengthene ...
... • Modified to serve as a point-of-care resource and to facilitate care transitions and coordination between specialty and primary care. • Patient-reported symptom assessment • Distinctions between medical and self-management strategies for prostate cancer treatment-related side effects • Strengthene ...
The Alvin J. Siteman Cancer Center is a National Cancer Institute
... medicine. Nanoparticles are used to locate and kill cancer cells by delivering toxic drugs directly to the tumor, without injuring normal tissue. ...
... medicine. Nanoparticles are used to locate and kill cancer cells by delivering toxic drugs directly to the tumor, without injuring normal tissue. ...
The Prostate Gland and PSA (Prostate Specific Antigen)
... fibromuscular zone is nonglandular and consists of a band of smooth muscle fibers and connective tissue that adjoins the smooth muscle of the bladder and the external sphincter and that prevents the back flow of semen into the bladder 3. Pathology of the Prostate The prostate remains functional and ...
... fibromuscular zone is nonglandular and consists of a band of smooth muscle fibers and connective tissue that adjoins the smooth muscle of the bladder and the external sphincter and that prevents the back flow of semen into the bladder 3. Pathology of the Prostate The prostate remains functional and ...
Prostate Cancer infographic v08
... precise scope of these relationships has been complicated partly by the methodological issue of “abstainer bias” ...
... precise scope of these relationships has been complicated partly by the methodological issue of “abstainer bias” ...
Comparing the Age at Prostate Cancer Diagnosis in Humans and
... of patients treated for locally advanced rectal cancer. The authors conclude, "Use of combined chemotherapy and radiation therapy as an adjuvant to surgery for patients with poor-prognosis resectable rectal cancer is justified." To which may be added—in comparison with postoperative adjuvant radiati ...
... of patients treated for locally advanced rectal cancer. The authors conclude, "Use of combined chemotherapy and radiation therapy as an adjuvant to surgery for patients with poor-prognosis resectable rectal cancer is justified." To which may be added—in comparison with postoperative adjuvant radiati ...
Update on PSA screening - Afzal -09-11-16
... with a PSA level of > 1 ng/mL at 40 years of age • men with a PSA level of > 2 ng/mL at 60 years of age 2b A A risk-adapted strategy might be considered (based on initial PSA level), which may be every 2 years for those initially at risk, or postponed up to 8 years in those not at risk. 3 C ...
... with a PSA level of > 1 ng/mL at 40 years of age • men with a PSA level of > 2 ng/mL at 60 years of age 2b A A risk-adapted strategy might be considered (based on initial PSA level), which may be every 2 years for those initially at risk, or postponed up to 8 years in those not at risk. 3 C ...
Read the article here from NEJM
... presentation can be detected ear lier than it once was — albeit with no change in the risk of death.5 Earlier diagnosis may be possible for women with cancers that would ultimately become metastatic — but not for some women presenting with metasta ses — because the two groups have different diseas ...
... presentation can be detected ear lier than it once was — albeit with no change in the risk of death.5 Earlier diagnosis may be possible for women with cancers that would ultimately become metastatic — but not for some women presenting with metasta ses — because the two groups have different diseas ...
Trends in Metastatic Breast and Prostate Cancer — Lessons in
... presentation can be detected ear lier than it once was — albeit with no change in the risk of death.5 Earlier diagnosis may be possible for women with cancers that would ultimately become metastatic — but not for some women presenting with metasta ses — because the two groups have different diseas ...
... presentation can be detected ear lier than it once was — albeit with no change in the risk of death.5 Earlier diagnosis may be possible for women with cancers that would ultimately become metastatic — but not for some women presenting with metasta ses — because the two groups have different diseas ...
Value of Prostate-Specific Antigen and Prostate
... 12 mL to 220 mL). Prostate cancer was diagnosed in 121 patients (36.7%) and benign lesions comprising BPH with or without prostatitis, in 209 (63.3%). Among patients without prostate cancer, the most common pathology was chronic prostatitis (79 of 209; 37.8%). Patients with prostate cancer had a sig ...
... 12 mL to 220 mL). Prostate cancer was diagnosed in 121 patients (36.7%) and benign lesions comprising BPH with or without prostatitis, in 209 (63.3%). Among patients without prostate cancer, the most common pathology was chronic prostatitis (79 of 209; 37.8%). Patients with prostate cancer had a sig ...
Leading cause of premature mortality in Australia fact sheet: prostate
... examination. Neither are diagnostic tests but rather indicate an increased risk of prostate cancer. A biopsy is needed to confirm diagnosis (AIHW 2013). ...
... examination. Neither are diagnostic tests but rather indicate an increased risk of prostate cancer. A biopsy is needed to confirm diagnosis (AIHW 2013). ...
PRESS RELEASE - Sexual Advice Association
... What the judges said: “This is exactly what is needed. For so many doctors, it’s a sensitive and awkward subject that is hopelessly addressed and ignored by many clinicians. This booklet answers the tough questions that are difficult to answer.” Dr Brandenburg said: "Sexual problems are amongst the ...
... What the judges said: “This is exactly what is needed. For so many doctors, it’s a sensitive and awkward subject that is hopelessly addressed and ignored by many clinicians. This booklet answers the tough questions that are difficult to answer.” Dr Brandenburg said: "Sexual problems are amongst the ...